News
Recent News
Join us at the 2019 New England Immunology Conference!
We will be presenting data on AnTolRx's antigen-specific nanoformulation platform. Join us in Woods Hole, MA, on October 12-13th, 2019. http://www.newenglandimmunology.org
Join us at the Antigen-Specific Immune Tolerance Drug Development Conference!
Dr. Sara Tezza will be presenting data on AnTolRx's antigen-specific nanoformulation platform. Join us in Boston March 26-28, 2019. http://as-immunetolerance.com
Meet us at the JP Morgan Healthcare Conference 2019!
We are excited to attend this year's 37th annual JP Morgan Healthcare conference in San Francisco, CA this Monday January 7th through the 10th.
Mark Carthy, CEO of AnTolRx, speaks at the World Vaccine Congress in Washington, DC
World Vaccine Congress Investor Panel, April 4th “…..Mr Carthy commented that “antigen specific tolerance has the potential to deliver disease modifying therapy for indications including autoimmune, allergies and protein drug antibody reactions. AnTolRx has...
Press Releases
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.